The impact to revenues for the three and nine months ended September 30, 2018 related to these adjustments was a decrease of $7.2 million and $28.6 million, respectively.
Public offering.
The increase in investments was the result of acquiring the net assets of DST in the second quarter of 2018.
The amount of revenues recognized in the period that was included in the opening deferred revenues balance was $33.1 million and $164.1 million for the three and nine months ended September 30, 2018, respectively.
The Company’s healthcare solutions include claims adjudication, benefit management, care management, business intelligence and other ancillary services.
All changes in fair value of the economic hedges were recorded in Other income (expense), net, during the three and nine months ended September 30, 2018 and resulted in expense of $0.5 million and $0.9 million, respectively.
The Company reported revenues of $3.7 million and $1,030.3 million from CACEIS and DST, respectively, from their respective acquisition dates through September 30, 2018.
ASU 2016-13 is effective for the Company for its first quarter of fiscal 2020 and earlier adoption is permitted beginning in the first quarter of fiscal 2019.
The Company also uses its own software applications to provide healthcare organizations a variety of medical and pharmacy benefit solutions to satisfy their information processing, quality of care, cost management concerns and payment integrity programs.
Under these arrangements, the client does not have the right to take possession of the software, rather, the Company agrees to provide access to its applications, remote use of its equipment to process transactions, access to client’s data stored on its equipment, and connectivity between its environment and the client’s computing systems.Transaction expenses are those costs that are directly related to our acquisition of DST.
We had other income, net of $13.7 million and $14.8 million for the three and nine months ended September 30, 2018, respectively.
Interest expense, net.
These facilities are discussed further in “Liquidity and Capital Resources”.
The increase in cash, cash equivalents and restricted cash and cash equivalents is primarily due to proceeds received from our borrowings and common stock offering, the impact of restricted cash and cash equivalents held by DST as well as cash provided by operations and proceeds from stock option exercises.
We funded the acquisition with a combination of cash and $875.0 million in incremental term loan debt.
The increase in total operating expenses in 2018 was primarily due to our acquisitions, which added expenses of $121.5 million and $356.9 million for the three and nine months ended September 30, 2018, respectively.During the nine months ended September 30, 2018, approximately 28% of our revenues were from clients located outside the United States.